Vaccsys, a company that does vaccine research, has raised $9 million of a planned $18 million round from Alta Partners, Versant Venture Capital and The Column Group.
Vaccsys’s web site is here, although it’s still under construction.
Update: As part of the new funding, Vaccsys is relaunching under a new name, Immune Design, according to VentureWire.
Trackback URL
